BCYC Q2 2019 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena

BCYCBicycle Therapeutics plc

$360M

Q2 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-8.4% YoY

Gross Profit

-$5M-329.5% margin

Operating Income

-$8M-524.8% margin

Net Income

-$10M-671.3% margin

EPS (Diluted)

$-1.40

QoQ Revenue Growth

-76.2%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$905,000

Balance Sheet

Total Assets

$126M

Total Liabilities

$22M

Stockholders' Equity

$105M

Cash & Equivalents

$109M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$2M	-8.4%
Gross Profit	-$5M	-$3M	-54.0%
Operating Income	-$8M	-$5M	-61.1%
Net Income	-$10M	-$5M	-105.2%